Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seasonal influenza vaccine immunogenicity and safety in psoriasis or psoriatic arthritis patients treated with secukinumab or apremilast
MOH_2019-04-28_007098Phase 3Completed
- Sponsor
- פרופ' אורי אלקיים
- Start
- Sep 2017
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of influenza vaccine, secukinumab and apremilast in influenza (3 arms), sponsored by פרופ' אורי אלקיים. Started Sep 2017; status: completed.
02
Drugs
influenza vaccinesecukinumabapremilast
03
Conditions
influenza
Beyond the preview
Go deeper on MOH_2019-04-28_007098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-04-28_007098.